Skip to content
10-Q

Quarterly Report

IGC Pharma, Inc. IGC

0001185185-25-001752

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Oct 30, 2025 92.87M sh
Shares Diluted Q2 2026 · Sep 30, 2025 90.46M sh
Shares Diluted Q2 2026 · Sep 30, 2025 86.76M sh
Shares Diluted Q2 2026 · Sep 30, 2024 76.01M sh
Shares Diluted Q2 2026 · Sep 30, 2024 74.42M sh
Capex Q2 2026 · Sep 30, 2025 $37K
Capex Q2 2026 · Sep 30, 2024 $67K
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$3.5M
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$2.75M
Long Term Debt Q2 2026 · Sep 30, 2025 $132K
Long Term Debt Q2 2026 · Mar 31, 2025 $134K
Short Term Debt Q2 2026 · Sep 30, 2025 $4K
Short Term Debt Q2 2026 · Mar 31, 2025 $3K
Short Term Investments Q2 2026 · Sep 30, 2025 $25K
Short Term Investments Q2 2026 · Mar 31, 2025 $0
Cash And Equivalents Q2 2026 · Sep 30, 2025 $1.11M
Cash And Equivalents Q2 2026 · Mar 31, 2025 $405K
Stockholders Equity Q2 2026 · Sep 30, 2025 $8.09M
Stockholders Equity Q2 2026 · Jun 30, 2025 $6.08M
Stockholders Equity Q2 2026 · Mar 31, 2025 $6.33M
Stockholders Equity Q2 2026 · Sep 30, 2024 $7.38M
Stockholders Equity Q2 2026 · Jun 30, 2024 $7.88M
Stockholders Equity Q2 2026 · Mar 31, 2024 $7.32M
Current Liabilities Q2 2026 · Sep 30, 2025 $1.51M
Current Liabilities Q2 2026 · Mar 31, 2025 $2.26M
Total Liabilities Q2 2026 · Sep 30, 2025 $1.65M
Total Liabilities Q2 2026 · Mar 31, 2025 $2.42M
Current Assets Q2 2026 · Sep 30, 2025 $2M
Current Assets Q2 2026 · Mar 31, 2025 $2.9M
Total Assets Q2 2026 · Sep 30, 2025 $9.74M
Total Assets Q2 2026 · Mar 31, 2025 $8.75M
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.02
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.04
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.02
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.06
Eps Basic Q2 2026 · Sep 30, 2025 −$0.02
Eps Basic Q2 2026 · Sep 30, 2025 −$0.04
Eps Basic Q2 2026 · Sep 30, 2024 −$0.02
Eps Basic Q2 2026 · Sep 30, 2024 −$0.06
Sga Expense Q2 2026 · Sep 30, 2025 $1.41M
Sga Expense Q2 2026 · Sep 30, 2025 $2.62M
Sga Expense Q2 2026 · Sep 30, 2024 $1.04M
Sga Expense Q2 2026 · Sep 30, 2024 $2.71M
Rd Expense Q2 2026 · Sep 30, 2025 $1.59M
Rd Expense Q2 2026 · Sep 30, 2025 $2.44M
Rd Expense Q2 2026 · Sep 30, 2024 $917K
Rd Expense Q2 2026 · Sep 30, 2024 $1.81M
Net Income Q2 2026 · Sep 30, 2025 −$1.82M
Net Income Q2 2026 · Sep 30, 2025 −$3.42M
Net Income Q2 2026 · Sep 30, 2024 −$1.72M
Net Income Q2 2026 · Sep 30, 2024 −$4.1M
Operating Income Q2 2026 · Sep 30, 2025 −$2.9M
Operating Income Q2 2026 · Sep 30, 2025 −$4.8M
Operating Income Q2 2026 · Sep 30, 2024 −$1.76M
Operating Income Q2 2026 · Sep 30, 2024 −$4.16M
Gross Profit Q2 2026 · Sep 30, 2025 $99K
Gross Profit Q2 2026 · Sep 30, 2025 $253K
Gross Profit Q2 2026 · Sep 30, 2024 $198K
Gross Profit Q2 2026 · Sep 30, 2024 $361K
Cost Of Revenue Q2 2026 · Sep 30, 2025 $92K
Cost Of Revenue Q2 2026 · Sep 30, 2025 $266K
Cost Of Revenue Q2 2026 · Sep 30, 2024 $214K
Cost Of Revenue Q2 2026 · Sep 30, 2024 $323K
Revenue Q2 2026 · Sep 30, 2025 $191K
Revenue Q2 2026 · Sep 30, 2025 $519K
Revenue Q2 2026 · Sep 30, 2024 $412K
Revenue Q2 2026 · Sep 30, 2024 $684K